A detailed history of Commodore Capital LP transactions in Nkarta, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 4,662,073 shares of NKTX stock, worth $11.7 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
4,662,073
Previous 4,151,034 12.31%
Holding current value
$11.7 Million
Previous $24.5 Million 14.1%
% of portfolio
1.79%
Previous 2.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $2.31 Million - $4.09 Million
511,039 Added 12.31%
4,662,073 $21.1 Million
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $5.2 Million - $10.7 Million
986,034 Added 31.15%
4,151,034 $24.5 Million
Q1 2024

May 15, 2024

BUY
$5.59 - $15.71 $2.43 Million - $6.83 Million
435,000 Added 15.93%
3,165,000 $34.2 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $3.58 Million - $18 Million
2,730,000 New
2,730,000 $18 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $122M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Commodore Capital LP Portfolio

Follow Commodore Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Commodore Capital LP with notifications on news.